Clinical Trial Update: Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of ibrutinib and venetoclax in treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Ibrutinib (ibrutinib)
• Venetoclax (venetoclax)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Leukemia, Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2022-02-18